Berry Genomics Co.,Ltd (SHE:000710)
China flag China · Delayed Price · Currency is CNY
12.81
-0.19 (-1.46%)
Sep 26, 2025, 3:04 PM CST

Berry Genomics Co.,Ltd Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
9561,0591,1291,3431,3701,504
Upgrade
Other Revenue
17.8219.4721.9224.6452.4336.1
Upgrade
973.821,0781,1511,3681,4221,540
Upgrade
Revenue Growth (YoY)
-14.76%-6.36%-15.83%-3.81%-7.67%-4.78%
Upgrade
Cost of Revenue
561.55603.72668.26821.85827.75760.94
Upgrade
Gross Profit
412.27474.44483.16546.15594.43779.45
Upgrade
Selling, General & Admin
338.03357.18404.55463.21456.17403.15
Upgrade
Research & Development
108.1695.42110.01106.74128.23125.8
Upgrade
Other Operating Expenses
9.1310.644.673.762.840.31
Upgrade
Operating Expenses
584.15593.91682671.71640.85560.85
Upgrade
Operating Income
-171.87-119.47-198.84-125.56-46.41218.6
Upgrade
Interest Expense
-8.95-9.83-16.35-17.64-20.3-15.34
Upgrade
Interest & Investment Income
4.233.522.642.365.0544.05
Upgrade
Currency Exchange Gain (Loss)
-1.23-0.77-0.55-1.620.38-1.09
Upgrade
Other Non Operating Income (Expenses)
-1.65-2.59-0.372.79-5.26-7.34
Upgrade
EBT Excluding Unusual Items
-171.17-129.14-213.47-139.66-66.54238.88
Upgrade
Gain (Loss) on Sale of Investments
-37.9-40.18-82.67-144.31-49.13-
Upgrade
Gain (Loss) on Sale of Assets
1.561.74-0.01-0.350.26-0.45
Upgrade
Asset Writedown
-0.65-0.65-159.38-0.07-5.16-0.02
Upgrade
Other Unusual Items
-3.09-2.532.128.020.196.93
Upgrade
Pretax Income
-211.25-170.76-453.42-276.37-120.38245.34
Upgrade
Income Tax Expense
14.417.42-28.16-29.98-10.5239.65
Upgrade
Earnings From Continuing Operations
-225.65-188.18-425.27-246.4-109.86205.69
Upgrade
Minority Interest in Earnings
-3.28-4.25-1.93-2.53-0.964.97
Upgrade
Net Income
-228.93-192.43-427.2-248.93-110.82210.67
Upgrade
Net Income to Common
-228.93-192.43-427.2-248.93-110.82210.67
Upgrade
Net Income Growth
------46.07%
Upgrade
Shares Outstanding (Basic)
353354354307357357
Upgrade
Shares Outstanding (Diluted)
353354354307357357
Upgrade
Shares Change (YoY)
-0.02%0.00%15.04%-14.03%0.12%0.55%
Upgrade
EPS (Basic)
-0.65-0.54-1.21-0.81-0.310.59
Upgrade
EPS (Diluted)
-0.65-0.54-1.21-0.81-0.310.59
Upgrade
EPS Growth
------46.36%
Upgrade
Free Cash Flow
-28.7431.2255.91-52.13-242.6648.76
Upgrade
Free Cash Flow Per Share
-0.080.090.16-0.17-0.680.14
Upgrade
Gross Margin
42.34%44.01%41.96%39.92%41.80%50.60%
Upgrade
Operating Margin
-17.65%-11.08%-17.27%-9.18%-3.26%14.19%
Upgrade
Profit Margin
-23.51%-17.85%-37.10%-18.20%-7.79%13.68%
Upgrade
Free Cash Flow Margin
-2.95%2.90%4.86%-3.81%-17.06%3.17%
Upgrade
EBITDA
-107.27-43.23-98-33.4250.94295.5
Upgrade
EBITDA Margin
-11.02%-4.01%-8.51%-2.44%3.58%19.18%
Upgrade
D&A For EBITDA
64.676.24100.8492.1397.3576.9
Upgrade
EBIT
-171.87-119.47-198.84-125.56-46.41218.6
Upgrade
EBIT Margin
-17.65%-11.08%-17.27%-9.18%-3.26%14.19%
Upgrade
Effective Tax Rate
-----16.16%
Upgrade
Revenue as Reported
973.821,0781,1511,3681,4221,540
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.